GZMM and neoplasm: Since we observed a profound impact on MET-1 tumor-infiltrating myeloid cell populations upon AuPEI nanocomposite treatment in vivo, we sought to determine whether this phenomenon concurs with a change in tumor-infiltrating lymphocyte (TIL) subsets (Figure 5A).